Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

MTF to investigate bullying claims
Finance Exclusive

MTF to investigate bullying claims

Chief executive Chris Lamers said he takes the claims 'very seriously'.

Payments NZ could play key role in open banking standards
Finance

Payments NZ could play key role in open banking standards

A draft decision proposes an 18-month approval, rather than the five years requested.

Ben Moore 01 Jul 2024
Singapore becomes hot spot for M&A bankers hunting Asia deals
Finance

Singapore becomes hot spot for M&A bankers hunting Asia deals

The island is a magnet for parties interested in mergers and acquisitions.

Bloomberg 28 Jun 2024
Medicine working but business confidence continues to fall
Finance

Medicine working but business confidence continues to fall

Confidence in retail and construction rose, while other sectors were more downbeat.

Tom Raynel 27 Jun 2024